2021
DOI: 10.3892/etm.2021.10339
|View full text |Cite
|
Sign up to set email alerts
|

First Chinese patient with mental retardation‑40 due to a de novo CHAMP1 frameshift mutation: Case report and literature review

Abstract: Mental retardation-40 (MRD40) is a rare autosomal dominant neurodevelopmental disorder with a poor prognosis that is caused by a heterozygous mutation in chromosome alignment maintaining phosphoprotein 1 (CHAMP1). It was previously considered a non-syndromic disease due to the lack of specific external features. Only limited international reports describing CHAMP1 mutations are currently available. The present case study was the first to report on a Chinese patient with MRD40. The patient presented with severe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…Importantly, while most of the cases described until now [ 14 , 16 , 17 , 24 , 25 , 26 , 27 , 31 , 32 ] ( Table S1 ) present either with microcephaly (22/45) or normal head circumference (23/45), the patient described in this paper as well as only another patient identified by Levy et al in 2022 [ 16 ] present with macrocephaly, illustrating once more the clinical heterogeneity of this disease and highlighting the challenges encountered in the clinical diagnosis of patients affected with NDD. Furthermore, 10 out of the 45 cases described in the literature ( Table S1 ), in addition to our patient showed high sensitivity to pain.…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, while most of the cases described until now [ 14 , 16 , 17 , 24 , 25 , 26 , 27 , 31 , 32 ] ( Table S1 ) present either with microcephaly (22/45) or normal head circumference (23/45), the patient described in this paper as well as only another patient identified by Levy et al in 2022 [ 16 ] present with macrocephaly, illustrating once more the clinical heterogeneity of this disease and highlighting the challenges encountered in the clinical diagnosis of patients affected with NDD. Furthermore, 10 out of the 45 cases described in the literature ( Table S1 ), in addition to our patient showed high sensitivity to pain.…”
Section: Discussionmentioning
confidence: 99%
“…There are several genes mapped on chromosomes 13 and 18 recognized as the players in the maintenance of redox balance [ 60 ]. Chromosome 13 mapping demonstrated the presence of genes associated with copper transport (ATPase copper transporting beta; ATP7B ), tumor suppression (breast cancer 2; BRCA2 ), the inhibition of cell cycle processes, chromatin remodeling (retinoblastoma transcriptional corepressor 1; RB1 ), chromosome stability maintenance and regulations of chromosome segregation in mitosis (chromosome alignment-maintaining phosphoprotein 1; CHAMP1 ), and oxidative mitochondrial processes (mitochondrial intermediate peptidase; MIPEP ), all of which are relevant in T13 pathogenesis [ 61 , 62 , 63 , 64 ]. The proper expression of the ATP7B gene is implicated in copper homeostasis, the deregulation of which may result in the development of many pathologies, especially those related to metabolic, cardiovascular and neurodegenerative diseases, and cancer [ 65 ].…”
Section: Genetic Basis Of the T13 And T18 Pathogenesesmentioning
confidence: 99%